115 related articles for article (PubMed ID: 12126815)
1. Seminal pharmaceutical trials: maintaining masking in analysis.
Boers M
Lancet; 2002 Jul; 360(9327):100-1. PubMed ID: 12126815
[No Abstract] [Full Text] [Related]
2. [Financial interests characterize published reports on coxiber. Whom can we rely on?].
Håkansson J
Lakartidningen; 2002 Oct; 99(40):3930-1. PubMed ID: 12422746
[No Abstract] [Full Text] [Related]
3. [Rapid, strong and long-term effectiveness. Coxib also effective in toothache].
MMW Fortschr Med; 2003 Jan; 145(1-2):53. PubMed ID: 12638443
[No Abstract] [Full Text] [Related]
4. Why don't we initiate more large simple randomized controlled trials?
Wright JM
CMAJ; 2003 Nov; 169(11):1170-1. PubMed ID: 14638653
[No Abstract] [Full Text] [Related]
5. What's all the fuss? Safety concerns about COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex).
Wooltorton E
CMAJ; 2002 Jun; 166(13):1692-3. PubMed ID: 12126328
[No Abstract] [Full Text] [Related]
6. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results].
Oliw E; Wollheim FA
Lakartidningen; 2000 Jun; 97(24):2942-4. PubMed ID: 10900877
[No Abstract] [Full Text] [Related]
7. [The CLASS study and its scientific statement. Ethical publishing rules neglected].
Wollheim FA
Lakartidningen; 2002 Oct; 99(40):3934-5. PubMed ID: 12422748
[No Abstract] [Full Text] [Related]
8. [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart].
MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688204
[No Abstract] [Full Text] [Related]
9. Clinical trials. Nail-biting time for trials of COX-2 drugs.
Couzin J
Science; 2004 Dec; 306(5702):1673-5. PubMed ID: 15576585
[No Abstract] [Full Text] [Related]
10. [Thinking about the specific cyclooxygenase-2 inhibitors since its recommendation].
Shi G
Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):579-80. PubMed ID: 11758234
[No Abstract] [Full Text] [Related]
11. HMO drug formulary access increases for COX-2s.
Manag Care; 2002 Oct; 11(10):48. PubMed ID: 12415909
[No Abstract] [Full Text] [Related]
12. [Homeopathy suppresses COX- and LOX activity. Soft therapy for arthrosis ills].
MMW Fortschr Med; 2004 Jan; 146(5):47. PubMed ID: 15035421
[No Abstract] [Full Text] [Related]
13. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].
Patrignani P
Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604
[No Abstract] [Full Text] [Related]
14. New versus old drugs for arthritis.
Health News; 1999 Nov; 5(14):7. PubMed ID: 10624169
[No Abstract] [Full Text] [Related]
15. Comment on efficacy of rofecoxib and nimesulide in controlling post-extraction pain in oral surgery: a randomised comparative study.
Villa G
Curr Med Res Opin; 2004 Apr; 20(4):573-4; author reply 574. PubMed ID: 15119995
[No Abstract] [Full Text] [Related]
16. Raising the safety bar--the FDA's coxib meeting.
Okie S
N Engl J Med; 2005 Mar; 352(13):1283-5. PubMed ID: 15800221
[No Abstract] [Full Text] [Related]
17. Treating pain with COX-2 inhibitors.
Rodgers E
Nurse Pract; 1999 Nov; 24(11):95-6, 99-100, 102. PubMed ID: 10618817
[No Abstract] [Full Text] [Related]
18. Pain relief at a price. A blow to the heart?
Comarow A
US News World Rep; 2001 Sep; 131(8):45. PubMed ID: 11550395
[No Abstract] [Full Text] [Related]
19. The coxibs, selective inhibitors of cyclooxygenase-2.
FitzGerald GA; Patrono C
N Engl J Med; 2001 Aug; 345(6):433-42. PubMed ID: 11496855
[No Abstract] [Full Text] [Related]
20. [Cox-2 inhibitors in the focus. Rofecoxib as effective as the "classics"].
MMW Fortschr Med; 2001 Nov; 143(46):50-1. PubMed ID: 11759601
[No Abstract] [Full Text] [Related]
[Next] [New Search]
